Yes Buddfox, would say so, have a feeling we just may see the Uncondtional approval unfold after the FDA recommendation on Heartmate 11.........at a 64% success rate and patients bleeding and not surviving as long as VCR patients.............. the survival rate is poor.............makes VCR look GREAT with 85% success rate and a more advanced pump. I think Ventracor may just be the dark horse in this race.
Cheers dma
- Forums
- ASX - By Stock
- VCR
- major milestone in growth of left ventricular
VCR
ventracor limited
major milestone in growth of left ventricular , page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online